cellceutix is an emerging bio-pharmaceutical company
focusing in the areas of cancer
and inflammatory disease...
Press Release 11/7/2011

Cellceutix Files Investigational New Drug Application (IND) with FDA, Clinical Trials Planned at Dana-Farber/Harvard Cancer Center
 
 
Investor Relations

 
As a public company, we take transparency seriously. We consider it our obligation. To be kept informed on the latest goings-on here at Cellceutix, please sign up. After all, it's your company, too.

Call to action:












 
Stay in the Know
Talk to Us
SEC Filings
Stock Information